NCT02219971

Phase I Study of Kukoamine B Mesilate in Healthy Volunteers

Randomized, Double-blind Placebo-controlled Phase I Study to Assess Safety, Tolerance and Pharmacokinetics of a Single Intravenous Injection Kukoamine B Mesilate in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 52 (actual)
• Sponsor: Tianjin Chasesun Pharmaceutical Co., LTD · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to assess safety, tolerance and pharmacokinetics of a single intravenous injection Kukoamine B Mesilate in health volunteer

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Kukoamine B Mesilate	Kukoamine B Mesilate or placebo single-dose and intravenous(IV) drip for 1 hour in healthy volunteers.

Timeline

• Start date: 2014-08-01
• Primary completion: 2015-05-06
• Completion: 2015-05-06
• First posted: 2014-08-19
• Last updated: 2017-05-03

Locations

1 site across 1 country: China